EFEMP2 upregulates PD-L1 expression via EGFR/ERK1/2/c-Jun signaling to promote the invasion of ovarian cancer cellsXin Shen, Jie Chen|Cellular & Molecular Biology Letters|2023Cited by 24
PL04.13 Aumolertinib Maintenance after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer: Interim Results of the Phase III Study (POLESTAR)Jinming Yu, Chunyu Liu, Xun Zhang et al.|Journal of Thoracic Oncology|2024Cited by 17
Abstract 4504: Retrospective study of clinicopathologic factors associated with <i>ALK</i> rearrangement and survival outcome in Chinese patients with NSCLCXu‐Chao Zhang, Yi‐Long Wu, C. Blanckmeister et al.|Cancer Research|2012Cited by 3